Global $13.34 Bn Gynecology Drugs Markets, Competition, Forecasts & Opportunities, 2026
August 23, 2021 06:13 ET
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Gynecology Drugs Market, By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication, By Distribution Channel, By Region,...
Global Contraceptives Market Report 2021: Market to Reach $29.1 Billion by 2027 - Unmet Contraception Needs Signals Huge Market Penetration Opportunities
August 18, 2021 07:48 ET
|
Research and Markets
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Contraceptives Market to...
Insights on the Contraceptives Global Market to 2028 - Increasing Awareness About Sexually Transmitted Diseases Presents Opportunities
July 30, 2021 09:13 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel" report has been added to...
Global Non-hormonal Therapies for Women's Health Market Report 2021-2030: Current Market Landscape with Focus on Prescription Drugs & Future Potential of this Evolving Market
July 20, 2021 04:18 ET
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of...
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
April 30, 2021 11:01 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial...
New UNFPA data reveals that nearly 12 million women lost access to contraception due to disruptions caused by the pandemic, leading to 1.4 million unintended pregnancies
March 11, 2021 00:05 ET
|
UNFPA
New York, March 11, 2021 (GLOBE NEWSWIRE) -- UNFPA, the UN sexual and reproductive health agency, releases new data today indicating that nearly 12 million women in 115 countries lost access to...
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
March 01, 2021 16:05 ET
|
Agile Therapeutics, Inc.
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla®...
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
February 19, 2021 08:35 ET
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
U.S. Supreme Court Upholds Trump Administration’s Exemptions to Contraceptive Mandate
July 08, 2020 12:46 ET
|
First Liberty Institute
WASHINGTON, July 08, 2020 (GLOBE NEWSWIRE) -- The Supreme Court of the United States today held 7–2 in Little Sisters of the Poor. v. Pennsylvania, et al., that the Trump Administration has the...
Religious Liberty Firm to Supreme Court: End this Assault on Little Sisters of the Poor, Religious Organizations
March 10, 2020 09:59 ET
|
First Liberty Institute
WASHINGTON, March 10, 2020 (GLOBE NEWSWIRE) -- First Liberty Institute filed a friend-of-the-court brief in Little Sisters of the Poor v. Pennsylvania urging the Supreme Court of the United States...